Omi Japan Launches 'Omi-PHR™ for Pharma', a PHR Development Package for Pharmaceutical Companies

Omi Japan Co., Ltd. (Headquarters: Chuo-ku, Tokyo, President: Dang My Hanh, hereinafter: Omi Japan), the Japanese subsidiary of the Omi Group which develops healthcare DX globally, has started the rollout of 'Omi-PHR™ for Pharma', a PHR (Personal Health Record) development package for pharmaceutical companies. Based on the knowledge of PHR development that Omi Japan has cultivated thus far and in consideration of the needs of pharmaceutical companies, 'Omi-PHR™ for Pharma' is a development package in which functions are organized and reconfigured specifically for pharmaceutical companies. In addition, Omi Japan will exhibit at the Pharma IT & Digital Health Expo 2026 to be held at Tokyo Big Sight from Tuesday, April 21 to Thursday, April 23, 2026, and will introduce patient-centric data utilization solutions that support the Beyond the Pill strategies of pharmaceutical companies, including this package. Patient Support Required of Pharmaceutical Companies Beyond the Provision of Pharmaceuticals In recent years, in addition to providing pharmaceuticals themselves, pharmaceutical companies are required to support continuous patient treatment, improve medication adherence, enhance the patient experience including daily life, coordinate information with medical professionals, and further create new value through data utilization. These concepts are continuously discussed within the industry as 'Beyond the Pill' or 'Around the Pill', and the movement to expand the value provided to patients and medical professionals by combining digital technologies, services, and data is spreading. Amidst this, PHR, which can continuously record and utilize patients' daily data and self-reported data, is highly expected to be the foundation supporting both patient support and data utilization. In response to this market environment, Omi Japan decided to go a step beyond general PHR development support and newly launch 'Omi-PHR™ for Pharma', which packages functions in accordance with the requirements demanded by pharmaceutical companies. What is 'Omi-PHR™ for Pharma'? 'Omi-PHR™ for Pharma' is a PHR development package designed for pharmaceutical companies. It organizes the main functions necessary when pharmaceutical companies consider PHR utilization, assuming applications such as patient support, continuous medication support, collection of patient-reported outcomes, delivery of patient support programs, and utilization of real-world data. It is structured to be flexibly customizable according to each company's target disease, patient contact points, and operational policies. 1. Alert Function: A notification function for medication timing and forgotten inputs. It can be used to prevent forgetting to take medicine and support self-management. 2. Medication Management: A function that allows patients to record their medication status. It visualizes the continuation status of medication and supports adherence improvement. 3. PRO (Patient Reported Outcomes) Collection: A function where patients themselves can input and record their physical condition, symptoms, QOL (quality of life), etc. It captures subjective changes in patients' conditions and connects them to support and data utilization. 4. Vital/Health Data Integration: A function to automatically acquire data such as blood pressure, blood glucose level, weight, and step count from wearable devices and measurement equipment. It makes it easier to continuously track health status in daily life. 5. Collection and Analysis of Real World Data (RWD): A function to continuously collect and analyze actual data of daily life, such as medication status and physical condition. It leads not only to the improvement of patient support but also to research and development and post-marketing data utilization. 6. Integration with Doctors/Medical Institutions (Optional): An integration function for doctors and medical institutions to check data recorded by patients and utilize it for medical treatment and follow-ups. It enhances the quality of information sharing and backs up more appropriate support. 7. Delivery of Patient Support Programs (PSP): A function to deliver knowledge about diseases and medicines, lifestyle guidance content, etc. It can be used to promote disease understanding and support patients' behavioral changes and treatment continuation. 8. Continuous Medication Support (Questionnaires/Chat): A function that utilizes questionnaires and chats to alleviate patients' anxiety and maintain motivation. It supports the continuation of treatment through interactive communication. PHR App Image Two provision formats are available so that customers can choose according to their concepts and requirements: full-scratch PHR development, and Omi-PHR™ OEM utilizing an existing foundation. ① Full-scratch PHR Development Depending on the customer's requirements, we provide comprehensive support from requirement definition to design, development, and operation. In addition to UI/UX design tailored to the users, we realize seamless integration with external systems, including health checkup systems, core systems, and wearable devices.